Nivolumab and cabozantinib versus standard of care in renal cell carcinoma | Prof Thomas Powles at ECC 2015
Thomas Powles, MBBS, MRCP, MD, of Barts and The London School of Medicine and Dentistry, London, UK, discusses the results of clinical trials reported at the European Cancer Congress (ECC) 2015 in pat...
Author: EMJ
Added: 11/23/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Dentistry | Kidney Cancer | Politics | Renal Cell Carcinoma